Paper37123787
Dilated Cardiomyopathy: Beware of Diet Drugs Slimming the Heart.
Bhattad PB and 5 others. Cureus, 2023. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Dilated Cardiomyopathy: Beware of Diet Drugs Slimming the Heart. Papers, record 37123787. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37123787
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22406466 | Inverted takotsubo cardiomyopathy in a patient with essential thrombocythemia exposed to anagrelide and phentermine. | Int J Cardiol | 2012 | https://conductscience.org/library/papers/22406466 | PubMed |
| 2 | 9270617 | Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity. | Neurology | 1997 | https://conductscience.org/library/papers/9270617 | PubMed |
| 3 | 5479657 | A case of drug-induced (?) pulmonary hypertension. | Acta Med Scand | 1970 | https://conductscience.org/library/papers/5479657 | PubMed |
| 4 | 9437392 | Asymptomatic mitral and aortic valve disease is seen in half of the patients taking 'phen-fen'. | Arch Intern Med | 1998 | https://conductscience.org/library/papers/9437392 | PubMed |
| 5 | 10440587 | Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine. | Obes Res | 1999 | https://conductscience.org/library/papers/10440587 | PubMed |
| 6 | 33882682 | Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. | Circulation | 2021 | https://conductscience.org/library/papers/33882682 | PubMed |
| 7 | 24641701 | Update on obesity pharmacotherapy. | Ann N Y Acad Sci | 2014 | https://conductscience.org/library/papers/24641701 | PubMed |
| 8 | 9565497 | Endocardial fibrosis associated with fenfluramine-phentermine. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9565497 | PubMed |
| 9 | 33686912 | Supraventricular tachycardia with the use of phentermine: case report and review of literature. | Postgrad Med | 2021 | https://conductscience.org/library/papers/33686912 | PubMed |
| 10 | 32152496 | The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database. | Int J Obes (Lond) | 2020 | https://conductscience.org/library/papers/32152496 | PubMed |
| 11 | 30260248 | Mechanisms of toxic cardiomyopathy. | Clin Toxicol (Phila) | 2019 | https://conductscience.org/library/papers/30260248 | PubMed |
| 12 | 16984841 | Weight-reducing regimen associated with polymorphic ventricular tachycardia. | Am J Emerg Med | 2006 | https://conductscience.org/library/papers/16984841 | PubMed |
| 13 | 32789124 | Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine. | Eur J Case Rep Intern Med | 2020 | https://conductscience.org/library/papers/32789124 | PubMed |
| 14 | 23630412 | Phentermine and topiramate for the management of obesity: a review. | Drug Des Devel Ther | 2013 | https://conductscience.org/library/papers/23630412 | PubMed |
| 15 | 9280830 | Further cases of valvular heart disease associated with fenfluramine-phentermine. | N Engl J Med | 1997 | https://conductscience.org/library/papers/9280830 | PubMed |
| 16 | 16569079 | Safety of drug therapies used for weight loss and treatment of obesity. | Drug Saf | 2006 | https://conductscience.org/library/papers/16569079 | PubMed |
| 17 | 9742026 | Regression of multivalvular regurgitation after the cessation of fenfluramine and phentermine treatment. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9742026 | PubMed |
| 18 | 8727293 | Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. | Am J Forensic Med Pathol | 1996 | https://conductscience.org/library/papers/8727293 | PubMed |
| 19 | 8901674 | Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. | Circulation | 1996 | https://conductscience.org/library/papers/8901674 | PubMed |
| 20 | 18606338 | Cardiac arrest in the setting of diet pill consumption. | Am J Emerg Med | 2008 | https://conductscience.org/library/papers/18606338 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42871841 | Oral Obesity Medicines in the Era of Cardiovascular-Kidney-Metabolic Syndrome (CKM): Beyond Weight Loss Toward Disease Modification. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42871841 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37123787
GET https://conductscience.org/api/papers/v1/37123787/references?page=2